English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

A knowledge graph to interpret clinical proteomics data

MPS-Authors
/persons/resource/persons196483

Geyer,  Philipp E.
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons199541

Coscia,  Fabian
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78356

Mann,  Matthias
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

s41587-021-01145-6.pdf
(Publisher version), 4MB

Supplementary Material (public)

41587_2021_1145_MOESM1_ESM.pdf
(Supplementary material), 3MB

Citation

Santos, A., Colaco, A. R., Nielsen, A. B., Niu, L., Strauss, M., Geyer, P. E., et al. (2022). A knowledge graph to interpret clinical proteomics data. Nature Biotechnology, 40, 692-702. doi:10.1038/s41587-021-01145-6.


Cite as: https://hdl.handle.net/21.11116/0000-000A-11A5-8
Abstract
A knowledge graph platform integrates proteomics with other omics data and biomedical databases.
Implementing precision medicine hinges on the integration of omics data, such as proteomics, into the clinical decision-making process, but the quantity and diversity of biomedical data, and the spread of clinically relevant knowledge across multiple biomedical databases and publications, pose a challenge to data integration. Here we present the Clinical Knowledge Graph (CKG), an open-source platform currently comprising close to 20 million nodes and 220 million relationships that represent relevant experimental data, public databases and literature. The graph structure provides a flexible data model that is easily extendable to new nodes and relationships as new databases become available. The CKG incorporates statistical and machine learning algorithms that accelerate the analysis and interpretation of typical proteomics workflows. Using a set of proof-of-concept biomarker studies, we show how the CKG might augment and enrich proteomics data and help inform clinical decision-making.